Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of Butyrate and Inulin Supplementation on Glycemic Status, Lipid Profile and Glucagon-Like Peptide 1 Level in Patients with Type 2 Diabetes: A Randomized Double-Blind, Placebo-Controlled Trial.
Roshanravan N, Mahdavi R, Alizadeh E, Jafarabadi MA, Hedayati M, Ghavami A, Alipour S, Alamdari NM, Barati M, Ostadrahimi A. Roshanravan N, et al. Horm Metab Res. 2017 Nov;49(11):886-891. doi: 10.1055/s-0043-119089. Epub 2017 Sep 29. Horm Metab Res. 2017. PMID: 28962046 Clinical Trial.
Assessing the Effect of High Performance Inulin Supplementation via KLF5 mRNA Expression in Adults with Type 2 Diabetes: A Randomized Placebo Controlled Clinical Trail.
Ghavami A, Roshanravan N, Alipour S, Barati M, Mansoori B, Ghalichi F, Nattagh-Eshtivan E, Ostadrahimi A. Ghavami A, et al. Among authors: roshanravan n. Adv Pharm Bull. 2018 Mar;8(1):39-47. doi: 10.15171/apb.2018.005. Epub 2018 Mar 18. Adv Pharm Bull. 2018. PMID: 29670837 Free PMC article.
Effects of saffron supplementation on glycemia and inflammation in patients with type 2 diabetes mellitus: A randomized double-blind, placebo-controlled clinical trial study.
Mobasseri M, Ostadrahimi A, Tajaddini A, Asghari S, Barati M, Akbarzadeh M, Nikpayam O, Houshyar J, Roshanravan N, Alamdari NM. Mobasseri M, et al. Among authors: roshanravan n. Diabetes Metab Syndr. 2020 Jul-Aug;14(4):527-534. doi: 10.1016/j.dsx.2020.04.031. Epub 2020 Apr 29. Diabetes Metab Syndr. 2020. PMID: 32408117 Clinical Trial.
The interplay between fasting, gut microbiota, and lipid profile.
Mohammadzadeh A, Roshanravan N, Mesri Alamdari N, Safaiyan A, Mosharkesh E, Hadi A, Barati M, Ostadrahimi A. Mohammadzadeh A, et al. Among authors: roshanravan n. Int J Clin Pract. 2021 Oct;75(10):e14591. doi: 10.1111/ijcp.14591. Epub 2021 Aug 19. Int J Clin Pract. 2021. PMID: 34227218
Effects of sodium selenite and selenium-enriched yeast on cardiometabolic indices of patients with atherosclerosis: A double-blind randomized clinical trial study.
Khabbaz Koche Ghazi M, Ghaffari S, Naemi M, Salehi R, Taban Sadeghi M, Barati M, Namazi Shabestari A, Kafil B, Mesri Alamdari N, Soleimanzadeh H, Tarighat-Esfanjani A, Roshanravan N. Khabbaz Koche Ghazi M, et al. Among authors: roshanravan n. J Cardiovasc Thorac Res. 2021;13(4):314-319. doi: 10.34172/jcvtr.2021.51. Epub 2021 Dec 5. J Cardiovasc Thorac Res. 2021. PMID: 35047136 Free PMC article.
Sodium selenite and Se-enriched yeast supplementation in atherosclerotic patients: Effects on the expression of pyroptosis-related genes and oxidative stress status.
Roshanravan N, Koche Ghazi MK, Ghaffari S, Naemi M, Alamdari NM, Shabestari AN, Mosharkesh E, Soleimanzadeh H, Sadeghi MT, Alipour S, Bastani S, Tarighat-Esfanjani A. Roshanravan N, et al. Nutr Metab Cardiovasc Dis. 2022 Jun;32(6):1528-1537. doi: 10.1016/j.numecd.2022.02.014. Epub 2022 Mar 7. Nutr Metab Cardiovasc Dis. 2022. PMID: 35365371 Clinical Trial.
72 results